Citation Information :
Kuragayala SD, Sathyakumar S, Kotamarthy HB. Severe Cotrimoxazole-induced Hypoglycemia in a Patient with Pneumocystis jirovecii Pneumonia: A Case Report. 2024; 3 (2):43-45.
Aim: To report a case of prolonged severe hypoglycemia associated with cotrimoxazole in a nondiabetic human immunodeficiency syndrome (HIV)—positive patient.
Case description: We describe a case of cotrimoxazole-associated hypoglycemia in a 30-year-old nondiabetic HIV-positive patient. The patient developed hypoglycemia after she was started on cotrimoxazole for the treatment of Pneumocystis jirovecii. Her renal and hepatic function was normal. Serum insulin and C-peptide measured at the time of hypoglycemia were found to be significantly elevated. Hypoglycemia was managed with intravenous administration of dextrose and resolved after cotrimoxazole was withdrawn. We also review the literature regarding this uncommon adverse effect of the commonly used drug.
Huang YS, Yang JJ, Lee NY, et al. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review. Expert Rev Anti Infect Ther 2017;15(9):873–892. DOI: 10.1080/14787210.2017.1364991
Trimethoprim-sulfamethoxazole: An overview - UpToDate. [cited 2021 Sep 19]. Available from: https://www.uptodate.com/contents/trimethoprim-sulfamethoxazole-an-overview?search=trimethoprim%20sulfamethoxazole&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
Strevel EL, Kuper A, Gold WL. Severe and protracted hypoglycaemia associated with co-trimoxazole use. Lancet Infect Dis 2006;6(3):178–182. DOI: 10.1016/S1473-3099(06)70414-5
Williams JD. The Garrod Lecture. Selective toxicity and concordant pharmacodynamics of antibiotics and other drugs. J Antimicrob Chemother 1995;35(6):721–737. DOI: 10.1093/jac/35.6.721
Lee AJ, Maddix DS. Trimethoprim/sulfamethoxazole-induced hypoglycemia in a patient with acute renal failure. Ann Pharmacother 1997;31(6):727–732. DOI: 10.1177/106002809703100611
Nunnari G, Celesia BM, Bellissimo F, et al. Trimethoprim-sulfamethoxazole-associated severe hypoglycaemia: a sulfonylurea-like effect. Eur Rev Med Pharmacol Sci 2010;14(12):1015–1018.
Schattner A, Rimon E, Green L, et al. Hypoglycemia induced by co-trimoxazole in AIDS. BMJ 1988;297(6650):742. DOI: 10.1136/bmj.297.6650.742
Roustit M, Blondel E, Villier C, et al. Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patient. Ann Pharmacother 2010;44(4):764–767. DOI: 10.1345/aph.1M597
Wen X, Wang JS, Backman JT, et al. Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively. Drug Metab Dispos 2002;30(6):631–635. DOI: 10.1124/dmd.30.6.631
Conley TE, Mohiuddin A, Naz N. Severe co-trimoxazole-induced hypoglycaemia in a patient with microscopic polyangiitis. BMJ Case Rep 2017;2017. DOI: 10.1136/bcr-2016-218976
Rivey MP, Taylor JW, Mullenix TA. TMP/SMX in renally impaired patients with P. carinii pneumonia. DICP 1989;23(9):687–689.
Mathews WA, Manint JE, Kleiss J. Trimethoprim-sulfamethoxazole-induced hypoglycemia as a cause of altered mental status in an elderly patient. J Am Board Fam Pract 2000;13(3):211–212. DOI: 10.3122/15572625-13-3-211
Johnson JF, Dobmeier ME. Symptomatic hypoglycemia secondary to a glipizide-trimethoprim/sulfamethoxazole drug interaction. DICP 1990;24(3):250–251. DOI: 10.1177/106002809002400307
Tan A, Holmes HM, Kuo YF, et al. Coadministration of co-trimoxazole with sulfonylureas: hypoglycemia events and pattern of use. J Gerontol A Biol Sci Med Sci 2015;70(2):247–254. DOI: 10.1093/gerona/glu072
Senanayake R, Mukhtar M. Cotrimoxazole-induced hypoglycaemia in a patient with churg-strauss syndrome. Case Rep Endocrinol 2013;2013:415810. DOI: 10.1155/2013/415810
Mah JK, Negreanu D, Radi S, et al. Trimethoprim-sulfamethoxazole-induced refractory hypoglycaemia successfully treated with octreotide. BMJ Case Rep 2021;14(5). DOI: 10.1136/bcr-2020-240232
Gonc EN, Turul T, Yordam N, et al. Trimethoprim-sulfamethoxazole induced prolonged hypoglycemia in an infant with MHC class II deficiency: diazoxide as a treatment option. J Pediatr Endocrinol Metab 2003;16(9):1307–1309. DOI: 10.1515/jpem.2003.16.9.1307
Kenteu B, Noubiap JJ, Etoa MC, et al. Acute glycaemic effects of co-trimoxazole at prophylactic dose in healthy adults. BMC Endocr Disord 2016;16(1):62. DOI: 10.1186/s12902-016-0142-6